{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:56:25Z","timestamp":1791597385760,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.radonc.2025.111328","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:57:19Z","timestamp":1765421839000},"page":"111328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Consolidative thoracic radiotherapy in the immunotherapy era for extensive-stage small cell lung cancer: a systematic review and meta-analysis with emphasis on brain and liver metastases"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9790-2803","authenticated-orcid":false,"given":"Dominik","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Wojewoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2766-4819","authenticated-orcid":false,"given":"Wiktoria","family":"Zi\u00f3\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-5201","authenticated-orcid":false,"given":"Pawe\u0142 Micha\u0142","family":"Potocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-3285","authenticated-orcid":false,"given":"J\u0119drzej","family":"Borowczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111328_b0005","unstructured":"SEER Cancer Statistics Review, 1975-2010 - Previous Version - SEER Cancer Statistics Review n.d. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2010\/ (accessed August 31, 2025)."},{"key":"10.1016\/j.radonc.2025.111328_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-319-40389-2_14","article-title":"Small cell lung cancer","volume":"170","author":"Bernhardt","year":"2016","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.radonc.2025.111328_b0015","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1148\/rg.346140178","article-title":"Small cell lung carcinoma: staging, imaging, and treatment considerations","volume":"34","author":"Carter","year":"2014","journal-title":"Radiographics"},{"key":"10.1016\/j.radonc.2025.111328_b0020","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.111328_b0025","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111328_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251326705","article-title":"Current and future perspectives in extensive-stage small-cell lung cancer","volume":"17","author":"Lim","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0035","unstructured":"Small cell lung cancer treatment (PDQ\u00ae) 2025. https:\/\/www.cancer.gov\/types\/lung\/hp\/small-cell-lung-treatment-pdq (accessed October 6, 2025)."},{"key":"10.1016\/j.radonc.2025.111328_b0040","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.21037\/jtd.2020.03.15","article-title":"What is the role of consolidative thoracic radiotherapy in the era of chemoimmunotherapy for extensive stage small cell lung cancer?","volume":"12","author":"Higgins","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.radonc.2025.111328_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111328_b0050","article-title":"Incidences of pneumonitis associated with the combination of radiotherapy and immune checkpoint inhibitors in lung cancer: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0055","first-page":"1","article-title":"Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer","author":"Huang","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3892\/ol.2012.792","article-title":"Specific organ metastases and survival in small cell lung cancer","volume":"4","author":"Nakazawa","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2025.111328_b0065","first-page":"372","article-title":"statement: an updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"The BMJ"},{"key":"10.1016\/j.radonc.2025.111328_b0070","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.radonc.2025.111328_b0075","doi-asserted-by":"crossref","unstructured":"Munn Z, MClinSc SM, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare 2015;13:147\u201353. https:\/\/doi.org\/10.1097\/XEB.0000000000000054.","DOI":"10.1097\/XEB.0000000000000054"},{"key":"10.1016\/j.radonc.2025.111328_b0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2025.111328_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.radonc.2025.111328_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2025.111328_b0095","doi-asserted-by":"crossref","unstructured":"azquez-Urrutia JR, Venugopal N, Zhu J, Miccio JA, Machtay M, Komiya T. Evaluating the role of consolidative chest radiotherapy after chemoimmunotherapy in extensive-stage small cell lung cancer: a retrospective study. Discover Oncology 2025;16. https:\/\/doi.org\/10.1007\/S12672-025-02589-X.","DOI":"10.1007\/s12672-025-02589-x"},{"key":"10.1016\/j.radonc.2025.111328_b0100","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.21037\/tlcr-23-294","article-title":"Safety and efficacy of thoracic radiotherapy combined with chemoimmunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis","volume":"12","author":"Cai","year":"2023","journal-title":"Trans. Lung Cancer Res."},{"key":"10.1016\/j.radonc.2025.111328_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083631","article-title":"Benefit of consolidation thoracic radiotherapy in extensive-stage small-cell lung cancer patients treated with immunotherapy: data from slovenian cohort","volume":"26","author":"\u010cak\u0161","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2025.111328_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102795","article-title":"Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small\u2013cell lung cancer (ES-SCLC): a phase II trial","volume":"75","author":"Chen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.radonc.2025.111328_b0115","article-title":"Consolidative thoracic radiation therapy after first-line chemotherapy and immunotherapy in extensive-stage small cell lung cancer: a multi-institutional case series","volume":"7","author":"Diamond","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10585-023-10227-5","article-title":"Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world","volume":"40","author":"Fang","year":"2023","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.radonc.2025.111328_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-025-03157-1","article-title":"Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis","volume":"26","author":"Huang","year":"2025","journal-title":"Respir Res"},{"key":"10.1016\/j.radonc.2025.111328_b0130","article-title":"First-line atezolizumab\/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0135","article-title":"Role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: a retrospective study","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.radonc.2025.111328_b0140","article-title":"Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2025.111328_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289434","article-title":"Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy","volume":"14","author":"Longo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2025.111328_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115592","article-title":"Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: a multicentric retrospective analysis","volume":"225","author":"Monaca","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70175","article-title":"Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients","volume":"13","author":"Mu","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2025.111328_b0160","doi-asserted-by":"crossref","unstructured":"Peng J, Zhang L, Wang L, Feng H, Yao D, Meng R, et al. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer. Radiation Oncology (London, England) 2023;18. https:\/\/doi.org\/10.1186\/S13014-023-02308-2.","DOI":"10.1186\/s13014-023-02308-2"},{"key":"10.1016\/j.radonc.2025.111328_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-11833-6","article-title":"Efficacy and safety of anti-PD-1 inhibitor versus anti-PD-L1 inhibitor in first-line treatment of extensive-stage small cell lung cancer: a multicenter retrospective study","volume":"24","author":"Qin","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113828","article-title":"Real-world efficacy and safety of thoracic radiotherapy after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer","volume":"12","author":"Xie","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2025.111328_b0175","article-title":"Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis","volume":"19","author":"Yao","year":"2024","journal-title":"Radiation Oncol. (London, England)"},{"key":"10.1016\/j.radonc.2025.111328_b0180","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2542434","article-title":"Consolidative thoracic radiotherapy improves the prognosis of extensive stage small-cell lung cancer patients in the chemoimmunotherapy era: a multicenter retrospective analysis","volume":"57","author":"Yao","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.radonc.2025.111328_b0185","article-title":"Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center","volume":"14","author":"Li","year":"2023","journal-title":"Discov Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0190","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70102","article-title":"The optimal radiotherapy strategy for patients with small cell lung cancer and brain metastasis: a retrospective analysis","volume":"30","author":"Zeng","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.radonc.2025.111328_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110014","article-title":"Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: a systematic review and meta-analysis","volume":"190","author":"Feng","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0200","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jtho.2017.06.015","article-title":"Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer (ED SCLC): NRG oncology RTOG 0937","volume":"12","author":"Gore","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21037\/atm-20-5765","article-title":"Role of thoracic radiotherapy in extensive stage small cell lung cancer: a systemic review and meta-analysis","volume":"9","author":"Li","year":"2021","journal-title":"Ann Trans Med"},{"key":"10.1016\/j.radonc.2025.111328_b0210","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2217\/fon-2017-0706","article-title":"The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study","volume":"14","author":"Cai","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.lungcan.2017.03.007","article-title":"Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: a secondary analysis of the phase III CREST trial","volume":"108","author":"Slotman","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0220","doi-asserted-by":"crossref","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nature Medicine 2021;27:152\u201364. https:\/\/doi.org\/10.1038\/S41591-020-1131-X,.","DOI":"10.1038\/s41591-020-1131-x"},{"key":"10.1016\/j.radonc.2025.111328_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70631","article-title":"Elevated neutrophil\u2010to\u2010lymphocyte ratio correlates with liver metastases and poor immunotherapy response in stage IV melanoma","volume":"14","author":"Foerster","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2025.111328_b0230","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4143\/crt.2023.931","article-title":"Intrathoracic progression is still the most dominant failure pattern after first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: implications for thoracic radiotherapy","volume":"56","author":"Kim","year":"2023","journal-title":"Cancer Res Treat : Official Journal of Korean Cancer Association"},{"key":"10.1016\/j.radonc.2025.111328_b0235","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111328_b0240","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70112","article-title":"The efficacy and safety of brain radiotherapy combined with immune checkpoint inhibitors (ICIs) for small-cell lung cancer (SCLC) patients with brain metastases (BMs)","volume":"16","author":"Xu","year":"2025","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0255","article-title":"A review of the abscopal effect in the era of immunotherapy","volume":"14","author":"Nabrinsky","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.radonc.2025.111328_b0260","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.radonc.2025.111328_b0265","first-page":"233","article-title":"The abscopal effect in patients with cancer receiving immunotherapy","volume":"4","author":"Nelson","year":"2023","journal-title":"Med (N Y)"},{"key":"10.1016\/j.radonc.2025.111328_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110837","article-title":"Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: an ESTRO clinical practice guideline","volume":"207","author":"De Ruysscher","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111328_b0275","first-page":"119","article-title":"Radiation-induced esophagitis in lung cancer","volume":"7","author":"Baker","year":"2016","journal-title":"Lung Cancer: Targets Therapy"},{"key":"10.1016\/j.radonc.2025.111328_b0280","article-title":"Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2025.111328_b0285","unstructured":"Clinicaltrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT04402788 (accessed October 6, 2025)."},{"key":"10.1016\/j.radonc.2025.111328_b0290","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1186\/s12885-022-10074-9","article-title":"Protocol of the treasure study: thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease - a randomized, open-label, multicenter phase II trial","volume":"22","author":"Bozorgmehr","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111328_b0295","doi-asserted-by":"crossref","unstructured":"Nosaki K, Zenke Y, Nomura S, Sasaki T, Niho S, Yoh K, et al. JCOG2002: A randomized phase III study of thoracic radiotherapy for extensive stage small cell lung cancer. J Clin Oncol 2024;42:TPS8132\u2013TPS8132. https:\/\/doi.org\/10.1200\/jco.2024.42.16_suppl.tps8132.","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS8132"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:22:31Z","timestamp":1781511751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025053320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":59,"alternative-id":["S0167814025053320"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111328","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consolidative thoracic radiotherapy in the immunotherapy era for extensive-stage small cell lung cancer: a systematic review and meta-analysis with emphasis on brain and liver metastases","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111328"}}